...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of health planning and management >The effect of the implementation of low price medicine policy on medicine price in China: A retrospective study
【24h】

The effect of the implementation of low price medicine policy on medicine price in China: A retrospective study

机译：低价医药政策实施对我国医学价格的影响：回顾性研究

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Summary In an effort to relieve the pressure of drug shortages, the Chinese government implemented Low‐price Medicines (LPM) policy to raise the price cap in July 2014. The purpose of this study is to examine the effect of the implementation of this policy on drug price in China. Price data of 491 LPM, including 218 low‐price chemical medicines (LPCM) and 273 low‐price traditional Chinese medicines (LPTCM), were collected from 699 hospitals. We used interrupted time series design to identify the variation of monthly Laspeyres Indexes (LI) and Paasche Indexes (PI) for LPM, LPCM, and LPTCM. The result demonstrated that although LPM expenditures increased, the proportion of LPM expenditures accounting for all medicine expenditures fell from 3.6% to 3.2%. After the implementation of LPM policy, there was a significant increasing trend in LPM‐PI, LPCM‐PI, and LPTCM‐PI. The trend in LPM‐LI and LPCM‐LI was found from descending to rising. However, for LPTCM, the trend in the LI remained to decrease after the policy implementation. Despite the LPM policy had an increasing impact on the LPM drug price, the proportion of LPM expenditures accounting for all medicine expenditures did not increase. More efforts are needed in the future to promote the rational drug use in China.
机译：总结努力减轻毒品短缺压力，中国政府实施了低价药物（LPM）政策，以便于2014年7月提高价格上限。本研究的目的是审查执行本政策的效果中国药品价格。 491升的价格数据，包括218个低价化学药物（LPCM）和273个低价中式药物（LPTCM），从699家医院收集。我们使用中断的时间序列设计来识别LPM，LPCM和LPTCM每月Laspeyres指数（Li）和Paasche指数（PI）的变化。结果表明，尽管LPM支出增加，但所有医学支出的LPM支出的比例从3.6％下降到3.2％。在实施LPM政策后，LPM-PI，LPCM-PI和LPTCM-PI存在显着增加的趋势。 LPM-Li和LPCM-Li的趋势被发现从下降到上升。但是，对于LPTCM，政策实施后李的趋势仍然减少。尽管LPM政策对LPM药品的影响越来越大，但LPM支出的比例占所有医学支出的核算并没有增加。未来需要更多努力，以促进中国的合理用药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号